Zobrazeno 1 - 10
of 130
pro vyhledávání: '"TAKAKO NOMURA"'
Autor:
Tomoko Tadokoro, Joji Tani, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Koji Fujita, Takako Nomura, Asahiro Morishita, Hideki Kobara, Takashi Himoto, Masafumi Ono, Tsutomu Masaki
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Portal vein thrombosis (PVT) worsens the long-term prognosis of patients with cirrhosis; however, the optimal treatment remains to be determined. Reports on the efficacy of direct oral anticoagulants are increasing, and further evidence is n
Externí odkaz:
https://doaj.org/article/edf0293d1b7b41aca4d8da2b8ed176f0
Autor:
Tomoko Tadokoro, Takako Nomura, Koji Fujita, Takushi Manabe, Kei Takuma, Mai Nakahara, Kyoko Oura, Shima Mimura, Joji Tani, Asahiro Morishita, Hideki Kobara, Masafumi Ono, Tsutomu Masaki
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Hepatocellular carcinoma (HCC) in autoimmune hepatitis (AIH) was considered rare but is increasing with prolonged prognosis. Its impact on the overall prognosis of AIH is unknown, and treatment has not been established. Aim To inv
Externí odkaz:
https://doaj.org/article/b1e1db6200a24ae49e2fc299f5bec07e
Autor:
Takashi Himoto, Koji Fujita, Takako Nomura, Joji Tani, Asahiro Morishita, Hirohito Yoneyama, Reiji Haba, Tsutomu Masaki
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 9, Iss 1, Pp 1-8 (2017)
Abstract Background Ten to forty percent of nonalcoholic steatohepatitis (NASH) and HCV-related chronic liver disease (CLD-C) patients have antinuclear antibodies (ANAs). However, the relationship between autoimmune response and insulin resistance re
Externí odkaz:
https://doaj.org/article/307c7e97d8264b9ca2e715ac17279335
Autor:
Kiyoyuki Kobayashi, Takako Nomura, Yuzuru Akaiwa, Tomohiro Ogi, Maki Ogi, Kayo Ishikawa, Masafumi Ono, Tsutomu Masaki
Publikováno v:
Kanzo. 64:194-200
Autor:
Joji Tani, Takaji Wakita, Asahiro Morishita, Hisakazu Iwama, Mai Nakahara, Koji Fujita, Kyoko Oura, Kunitada Shimotohno, Takahiro Masaki, Takako Nomura, Hirohito Yoneyama, Takashi Himoto, Tomoko Tadokoro, Hideki Kobara, Kei Takuma, Tsutomu Masaki, Kunihiko Tsutsui, Akihiro Deguchi, Shima Mimura, Teppei Sakamoto, Makoto Oryu
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:1126-1135
Background and aim Direct-acting antiviral (DAA) therapies have been proven to be highly effective for the eradication of hepatitis C virus (HCV) without resistance-associated substitutions (RASs). However, even in cases with no detected RASs, treatm
Autor:
Hideki Kobara, Tomoko Tadokoro, Takashi Himoto, Joji Tani, Hirohito Yoneyama, Koji Fujita, Tsutomu Masaki, Kyoko Oura, Mai Nakahara, Takako Nomura, Kei Takuma, Asahiro Morishita, Shima Mimura, Teppei Sakamoto
Publikováno v:
European Journal of Gastroenterology & Hepatology. 32:288-293
AIM The aim of this study was to determine whether oral L-carnitine administration reduces the blood ammonia concentration and number of hospital admissions for hepatic encephalopathy in patients with advanced cirrhosis. METHODS Of 68 patients with h
Autor:
Akira Nishiyama, Takako Nomura, Takashi Himoto, Joji Tani, Kei Takuma, Yasuyuki Suzuki, Tomoki Kohno, Keiichi Okano, Koji Fujita, Asahiro Morishita, Kyoko Oura, Hisakazu Iwama, Hirohito Yoneyama, Kiyohito Kato, Mai Nakahara, Tomoko Tadokoro, Tsutomu Masaki
Publikováno v:
Oncology Letters
Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Clinical management has improved the prognosis of early HCC, but that of advanced HCC remains poor. Sorafenib, an oral multikinase inhibitor, provided a trea
Autor:
Satoru Joshita, Mie Inao, Kazuhito Kawata, Mie Arakawa, Toshihiko Arizumi, Tadashi Namisaki, Norifumi Kawada, Minami Yagi, Atsushi Tanaka, Akira Kaneko, Keisuke Kakisaka, Kentaro Kikuchi, Takeji Umemura, Akira Honda, Kosuke Matsumoto, Jong-Hon Kang, Mitsuhiko Aiso, Satoshi Mochida, Hideki Fujii, Yamato Tamura, Naoaki Hashimoto, Masashi Ninomiya, Atsumasa Komori, Jun Itakura, Tsutomu Masaki, Takako Nomura, Atsushi Takahashi, Masaaki Takamura, Hajime Takikawa, Ryo Miura, Hitoshi Yoshiji, Hiromasa Ohira, Masanori Abe, Yasuhiro Takikawa, Ken Sato, Yoshinari Asaoka
Publikováno v:
Liver International. 40:1926-1933
BACKGROUND/PURPOSE Although ursodeoxycholic acid (UDCA) is a first-line treatment for primary biliary cholangitis (PBC), 20%-30% of patients with PBC exhibit an incomplete response to UDCA. Recently, the UDCA Response Score was proposed for predictin
Autor:
Akira Nishiyama, Kunitada Shimotohno, Takashi Himoto, Keiichi Okano, Yu Guan, Joji Tani, Kiyoyuki Kobayashi, Tomoko Tadokoro, Asahiro Morishita, Taiga Chiyo, Takako Nomura, Shima Mimura, Tsutomu Masaki, Koji Fujita, Kyoko Oura, Yasuyuki Suzuki, Hideki Kamada, Hisakazu Iwama, Shintaro Fujihara, Hirohito Yoneyama
Publikováno v:
American Journal of Physiology-Gastrointestinal and Liver Physiology. 318:G401-G409
Hepatitis B virus (HBV)-related hepatocarcinogenesis is not necessarily associated with the liver fibrotic stage and is occasionally seen at early fibrotic stages. MicroRNAs (miRNAs) are essentially 18- to 22-nucleotide-long endogenous noncoding RNAs
Autor:
Kyoko Oura, Asahiro Morishita, Joji Tani, Takako Nomura, Takushi Manabe, Kei Takuma, Mai Nakahara, Tomoko Tadokoro, Koji Fujita, Shima Mimura, Takayuki Sanomura, Yoshihiro Nishiyama, Tsutomu Masaki
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1834
Sarcopenia-related factors, including the skeletal muscle index (SMI), are reportedly associated with prognosis in patients with hepatocellular carcinoma (HCC) receiving various treatments. However, there is no evidence relating to hepatic arterial i